Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Response to Letter].

Kamaleldin B SaidAhmed AlsolamiFayez Saud AlreshidiAnas FathuddinFawwaz AlshammariFauwaz AlrashidAhmed AljadaniRana AborasFatmah AlreshidiMohammed H AlghozwiSuliman F AlshammariNawaf F Alharbi

Published in: Journal of multidisciplinary healthcare (2023)

Keyphrases

low dose
healthcare
sars cov
palliative care
high dose
genome wide
quality improvement
single cell
pain management
affordable care act
dna methylation
health insurance